News

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
World Health Organization (WHO) member countries adopted a new treaty on May 20, 2025, to improve international coordination ...
The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older ...
The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...